Dr. Scott Mcshane, DO

NPI: 1629330394
Total Payments
$4,793
2024 Payments
$991.50
Companies
29
Transactions
251
Medicare Patients
1,903
Medicare Billing
$252,858

Payment Breakdown by Category

Food & Beverage$4,689 (97.8%)
Education$103.29 (2.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,689 249 97.8%
Education $103.29 2 2.2%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $1,267 80 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $485.24 28 $0 (2024)
Janssen Biotech, Inc. $479.72 20 $0 (2024)
Valeant Pharmaceuticals North America LLC $278.43 13 $0 (2017)
Regeneron Healthcare Solutions, Inc. $251.66 13 $0 (2024)
Lilly USA, LLC $245.20 12 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $242.31 13 $0 (2024)
Gilead Sciences, Inc. $179.83 5 $0 (2019)
Merck Sharp & Dohme LLC $159.74 10 $0 (2022)
Celgene Corporation $147.56 7 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $991.50 47 ABBVIE INC. ($344.07)
2023 $752.69 35 ABBVIE INC. ($137.45)
2022 $359.70 18 ABBVIE INC. ($135.63)
2021 $134.55 5 Janssen Biotech, Inc. ($134.55)
2020 $127.35 8 AbbVie Inc. ($29.67)
2019 $957.40 55 AbbVie, Inc. ($251.92)
2018 $771.91 50 AbbVie, Inc. ($264.77)
2017 $697.48 33 Valeant Pharmaceuticals North America LLC ($278.43)

All Payment Transactions

251 individual payment records from CMS Open Payments — Page 1 of 11

Date Company Product Nature Form Amount Type
12/26/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $29.43 General
Category: Immunology
12/13/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $14.78 General
Category: GASTROENTEROLOGY
12/05/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $27.22 General
Category: Immunology
12/04/2024 Braintree Laboratories, Inc. SUFLAVE (Drug) Food and Beverage In-kind items and services $14.97 General
Category: GI COLON PREP
12/03/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $21.72 General
Category: INFLAMMATION AND IMMUNOLOGY
11/15/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $26.56 General
Category: Immunology
11/15/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $21.72 General
Category: INFLAMMATION AND IMMUNOLOGY
11/14/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $17.35 General
Category: INTERNAL MEDICINE
11/05/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $15.14 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
10/25/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $19.95 General
Category: INFLAMMATION AND IMMUNOLOGY
10/24/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $7.15 General
Category: IMMUNOLOGY
10/22/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $21.09 General
Category: INTERNAL MEDICINE
09/23/2024 Intercept Pharmaceuticals, Inc. OCALIVA (Drug) Food and Beverage In-kind items and services $15.91 General
Category: Hepatology / Gastroenterology
09/19/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $32.54 General
Category: Immunology
09/13/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $20.19 General
Category: INFLAMMATION AND IMMUNOLOGY
09/13/2024 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Food and Beverage In-kind items and services $18.65 General
Category: GASTROENTEROLOGY
09/06/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $26.56 General
Category: Immunology
09/04/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $19.04 General
Category: VIROLOGY
07/31/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $17.90 General
Category: IMMUNOLOGY
07/23/2024 ABBVIE INC. CREON (Drug) Food and Beverage In-kind items and services $12.86 General
Category: ENDOCRINOLOGY
07/17/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $23.70 General
Category: INFLAMMATION AND IMMUNOLOGY
07/15/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $34.40 General
Category: IMMUNOLOGY
07/11/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $18.18 General
Category: INTERNAL MEDICINE
07/01/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $17.55 General
Category: VIROLOGY
06/18/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $24.61 General
Category: IMMUNOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 435 2,698 $502,672 $110,689
2022 10 386 399 $236,300 $45,757
2021 10 609 622 $261,975 $54,992
2020 10 473 490 $176,515 $41,420
Total Patients
1,903
Total Services
4,209
Medicare Billing
$252,858
Procedure Codes
42

All Medicare Procedures & Services

42 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J1745 Injection, infliximab, excludes biosimilar, 10 mg Office 2023 15 2,240 $234,192 $58,185 24.8%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 79 79 $70,310 $15,790 22.5%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 96 97 $76,630 $12,350 16.1%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 93 97 $58,200 $7,874 13.5%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2023 16 35 $12,950 $3,702 28.6%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 21 21 $13,965 $3,401 24.4%
43248 Insertion of guide wire with dilation of esophagus using a flexible endoscope Facility 2023 23 24 $15,000 $2,781 18.5%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 13 13 $8,645 $2,323 26.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 24 26 $5,850 $2,283 39.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 12 12 $4,080 $1,342 32.9%
96415 Administration of chemotherapy into vein, each additional hour Office 2023 13 24 $2,400 $544.08 22.7%
82947 Blood glucose (sugar) level Office 2023 30 30 $450.00 $115.50 25.7%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 92 93 $82,770 $18,558 22.4%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 74 74 $58,460 $8,023 13.7%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 83 85 $51,000 $7,099 13.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 31 34 $7,650 $2,992 39.1%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2022 15 15 $9,975 $2,724 27.3%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 14 14 $9,310 $2,545 27.3%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2022 12 14 $5,180 $1,557 30.1%
43248 Insertion of guide wire with dilation of esophagus using a flexible endoscope Facility 2022 15 15 $9,375 $1,533 16.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 11 13 $1,950 $566.34 29.0%
82947 Blood glucose (sugar) level Office 2022 39 42 $630.00 $159.72 25.4%
45385 Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare Facility 2021 90 90 $80,100 $18,032 22.5%
45380 Biopsy of the large bowel using an endoscope (colonoscopy) Facility 2021 116 116 $91,640 $14,225 15.5%
43239 Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope Facility 2021 83 84 $50,400 $5,607 11.1%

About Dr. Scott Mcshane, DO

Dr. Scott Mcshane, DO is a Internal Medicine healthcare provider based in Spokane, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2012. The National Provider Identifier (NPI) number assigned to this provider is 1629330394.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Mcshane, DO has received a total of $4,793 in payments from pharmaceutical and medical device companies, with $991.50 received in 2024. These payments were reported across 251 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,689).

As a Medicare-enrolled provider, Mcshane has provided services to 1,903 Medicare beneficiaries, totaling 4,209 services with total Medicare billing of $252,858. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Gastroenterology
  • Location Spokane, WA
  • Active Since 06/08/2012
  • Last Updated 08/14/2023
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1629330394

Products in Payments

  • STELARA (Biological) $530.19
  • XIFAXAN (Drug) $453.34
  • Humira (Biological) $407.27
  • DUPIXENT (Biological) $333.88
  • RINVOQ (Biological) $192.13
  • OMVOH (Drug) $162.26
  • ENTYVIO (Biological) $161.89
  • MAVYRET (Drug) $159.59
  • ZEPOSIA (Drug) $147.56
  • Cimzia (Drug) $129.85
  • SKYRIZI (Biological) $124.95
  • Epclusa (Drug) $106.67
  • DIFICID (Drug) $95.00
  • Mavyret (Drug) $94.15
  • XIFAXANIBSD (Drug) $90.05
  • Creon (Drug) $87.84
  • Entyvio (Biological) $80.42
  • UCERIS (Drug) $79.27
  • CREON (Drug) $67.78
  • UCERIS TABLETS (Drug) $67.65

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Spokane